JP2023549229A5 - - Google Patents

Info

Publication number
JP2023549229A5
JP2023549229A5 JP2023528449A JP2023528449A JP2023549229A5 JP 2023549229 A5 JP2023549229 A5 JP 2023549229A5 JP 2023528449 A JP2023528449 A JP 2023528449A JP 2023528449 A JP2023528449 A JP 2023528449A JP 2023549229 A5 JP2023549229 A5 JP 2023549229A5
Authority
JP
Japan
Prior art keywords
referred
sequence
sar
peptide ligand
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2023528449A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023549229A (ja
JP7848202B2 (ja
Filing date
Publication date
Priority claimed from GBGB2017927.1A external-priority patent/GB202017927D0/en
Priority claimed from GBGB2106903.4A external-priority patent/GB202106903D0/en
Application filed filed Critical
Priority claimed from PCT/GB2021/052927 external-priority patent/WO2022101633A1/en
Publication of JP2023549229A publication Critical patent/JP2023549229A/ja
Publication of JP2023549229A5 publication Critical patent/JP2023549229A5/ja
Application granted granted Critical
Publication of JP7848202B2 publication Critical patent/JP7848202B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2023528449A 2020-11-13 2021-11-12 トランスフェリン受容体1(TfR1)に特異的な二環式ペプチドリガンド Active JP7848202B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
GBGB2017927.1A GB202017927D0 (en) 2020-11-13 2020-11-13 Bicyclic peptide ligands specific for transferrin
GB2017927.1 2020-11-13
GBGB2106903.4A GB202106903D0 (en) 2021-05-14 2021-05-14 Bicycle peptide ligands specific for transferrin
GB2106903.4 2021-05-14
US202163261820P 2021-09-29 2021-09-29
US63/261,820 2021-09-29
PCT/GB2021/052927 WO2022101633A1 (en) 2020-11-13 2021-11-12 BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR TRANSFERRIN RECEPTOR 1 (TfR1)

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2026063498A Division JP2026129727A (ja) 2020-11-13 2026-04-08 トランスフェリン受容体1(TfR1)に特異的な二環式ペプチドリガンド

Publications (3)

Publication Number Publication Date
JP2023549229A JP2023549229A (ja) 2023-11-22
JP2023549229A5 true JP2023549229A5 (cg-RX-API-DMAC7.html) 2024-11-21
JP7848202B2 JP7848202B2 (ja) 2026-04-20

Family

ID=81600834

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023528449A Active JP7848202B2 (ja) 2020-11-13 2021-11-12 トランスフェリン受容体1(TfR1)に特異的な二環式ペプチドリガンド

Country Status (13)

Country Link
US (3) US11970555B2 (cg-RX-API-DMAC7.html)
EP (1) EP4244235A1 (cg-RX-API-DMAC7.html)
JP (1) JP7848202B2 (cg-RX-API-DMAC7.html)
KR (1) KR20230107589A (cg-RX-API-DMAC7.html)
CN (1) CN116802190A (cg-RX-API-DMAC7.html)
AR (1) AR126029A1 (cg-RX-API-DMAC7.html)
AU (1) AU2021376917A1 (cg-RX-API-DMAC7.html)
CA (1) CA3201414A1 (cg-RX-API-DMAC7.html)
IL (1) IL302713A (cg-RX-API-DMAC7.html)
MX (1) MX2023005624A (cg-RX-API-DMAC7.html)
SA (1) SA523440745B1 (cg-RX-API-DMAC7.html)
TW (1) TWI921406B (cg-RX-API-DMAC7.html)
WO (1) WO2022101633A1 (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116802190A (zh) 2020-11-13 2023-09-22 拜斯科技术开发有限公司 特异于转铁蛋白受体1(TfR1)的双环肽配体
GB202206431D0 (en) * 2022-05-03 2022-06-15 Bicycletx Ltd Bicyclic peptide ligands specific for transferrin receptor 1 (TfR1)
KR20260021596A (ko) * 2023-04-05 2026-02-13 아이오니스 파마수티컬즈, 인코포레이티드 Pln 발현을 감소시키는 화합물 및 방법
EP4788689A1 (en) 2023-10-03 2026-08-12 BicycleTx Limited Bicyclic peptide ligand complexes specific for tfr1
GB202316970D0 (en) * 2023-11-06 2023-12-20 Bicycletx Ltd Bicyclic peptide ligands specific for transferrin receptor 1 (TfR1)

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6074574B2 (ja) 2008-02-05 2017-02-08 バイシクル セラピューティクス リミテッド 方法及び組成物
GB0914110D0 (en) 2009-08-12 2009-09-16 Medical Res Council Peptide libraries
CA2967830A1 (en) * 2014-11-14 2016-05-19 Ossianix, Inc. Tfr selective binding compounds and related methods
CN104650186A (zh) 2015-03-09 2015-05-27 中国药科大学 一种能够与TfR1特异性结合的活性肽及其应用
CA2990785C (en) * 2015-06-24 2024-11-12 Jcr Pharmaceuticals Co., Ltd. ANTI-HUMAN TRANSFERRIN RECEPTOR ANTIBODIES CROSSING THE BLOOD-BRAIN BARRIER
GB201706477D0 (en) 2017-04-24 2017-06-07 Bicycle Therapeutics Ltd Modification of polypeptides
EP3615550A1 (en) 2017-04-27 2020-03-04 BicycleTx Limited Bicyclic peptide ligands and uses thereof
JP7670481B2 (ja) 2017-08-04 2025-04-30 バイスクルテクス・リミテッド Cd137に対して特異的な二環式ペプチドリガンド
CA3080351A1 (en) 2017-11-02 2019-05-09 Ossianix, Inc. Improved tfr-selective binding peptides capable of crossing the blood brain barrier
CA3091775A1 (en) * 2018-02-23 2019-08-29 Bicycletx Limited Multimeric bicyclic peptide ligands
WO2020084305A1 (en) 2018-10-23 2020-04-30 Bicycletx Limited Bicyclic peptide ligands and uses thereof
EP3897849A1 (en) * 2018-12-21 2021-10-27 BicycleTx Limited Bicyclic peptide ligands specific for pd-l1
GB201912320D0 (en) * 2019-08-28 2019-10-09 Bicycletx Ltd PBP Binding Bicyclic Peptide Ligands
CN116802190A (zh) 2020-11-13 2023-09-22 拜斯科技术开发有限公司 特异于转铁蛋白受体1(TfR1)的双环肽配体

Similar Documents

Publication Publication Date Title
JP2022542291A5 (cg-RX-API-DMAC7.html)
JP2025122030A5 (cg-RX-API-DMAC7.html)
JP2022513223A5 (cg-RX-API-DMAC7.html)
JP2024062998A5 (cg-RX-API-DMAC7.html)
JP2022514618A5 (cg-RX-API-DMAC7.html)
KR101781841B1 (ko) 부갑상선 호르몬 수준을 감소시키기 위한 치료제
JP2022542386A5 (cg-RX-API-DMAC7.html)
JP2022544058A5 (cg-RX-API-DMAC7.html)
CN103533949B (zh) 作为缺血性脑损伤的有效神经保护剂并用于治疗疼痛的psd-95的高亲和力的二聚抑制剂
JP2022517040A5 (cg-RX-API-DMAC7.html)
JP2022512478A5 (cg-RX-API-DMAC7.html)
JP2022514255A5 (cg-RX-API-DMAC7.html)
JP2022518695A5 (cg-RX-API-DMAC7.html)
ES2669190T3 (es) Uso de péptidos intestinales vasoactivos modificados en el tratamiento de la hipertensión
CN110114065A (zh) 通过甲状旁腺激素受体刺激进行的骨折靶向性骨再生
PE20231506A1 (es) Peptidos y combinaciones de peptidos para su uso en inmunoterapia contra una infeccion por sars-cov-2 (covid-19)
CN116802190A (zh) 特异于转铁蛋白受体1(TfR1)的双环肽配体
ES2607986T3 (es) Agentes terapéuticos para regular el fósforo en suero
JP2023504904A5 (cg-RX-API-DMAC7.html)
ES2739543T3 (es) Péptido de terminal C de acetilcolinesterasa cíclico en el tratamiento o prevención de cáncer o metástasis
AU2012267470A1 (en) Therapeutic agents for regulating serum phosphorus
CN115636868A (zh) 一种基于阳离子纳米载体的多肽递送系统及其制备方法和用途
CN117120459A (zh) 抗感染双环肽配体
CN120478188B (zh) 保护毛发用、修复受损毛发用或强化毛发用组合物
RU2785401C2 (ru) Направленная регенерация переломанной кости посредством стимуляции рецептора паратиреоидного гормона